[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Bioengineered Protein Drugs Market Report 2017

December 2017 | 114 pages | ID: U3B5E27AE11EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Bioengineered Protein Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Bioengineered Protein Drugs in these regions, from 2012 to 2022 (forecast).
United States Bioengineered Protein Drugs market competition by top manufacturers/players, with Bioengineered Protein Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
  • Novartis
  • Sanofi
  • Eli Lilly
  • F. Hoffmann-La Roche
  • Dr. Reddy's Laboratories
  • Abbott Laboratories
  • Amgen
  • Bayer AG
  • Biocon
  • Fresenius kabi
  • Panacea Biotec
  • ProBioGen AG
  • Reliance Life Science
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Monoclonal Antibodies
  • Therapeutic Proteins
  • Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Pharma and Biotech Companies
  • CROs
  • Academics
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Bioengineered Protein Drugs Market Report 2017

1 BIOENGINEERED PROTEIN DRUGS OVERVIEW

1.1 Product Overview and Scope of Bioengineered Protein Drugs
1.2 Classification of Bioengineered Protein Drugs by Product Category
  1.2.1 United States Bioengineered Protein Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Bioengineered Protein Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Monoclonal Antibodies
  1.2.4 Therapeutic Proteins
  1.2.5 Vaccines
1.3 United States Bioengineered Protein Drugs Market by Application/End Users
  1.3.1 United States Bioengineered Protein Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Pharma and Biotech Companies
  1.3.3 CROs
  1.3.4 Academics
1.4 United States Bioengineered Protein Drugs Market by Region
  1.4.1 United States Bioengineered Protein Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Bioengineered Protein Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Bioengineered Protein Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Bioengineered Protein Drugs Status and Prospect (2012-2022)
  1.4.5 New England Bioengineered Protein Drugs Status and Prospect (2012-2022)
  1.4.6 The South Bioengineered Protein Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Bioengineered Protein Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Bioengineered Protein Drugs (2012-2022)
  1.5.1 United States Bioengineered Protein Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Bioengineered Protein Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES BIOENGINEERED PROTEIN DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Bioengineered Protein Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Bioengineered Protein Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Bioengineered Protein Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Bioengineered Protein Drugs Market Competitive Situation and Trends
  2.4.1 United States Bioengineered Protein Drugs Market Concentration Rate
  2.4.2 United States Bioengineered Protein Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Bioengineered Protein Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES BIOENGINEERED PROTEIN DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Bioengineered Protein Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Bioengineered Protein Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Bioengineered Protein Drugs Price by Region (2012-2017)

4 UNITED STATES BIOENGINEERED PROTEIN DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Bioengineered Protein Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Bioengineered Protein Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Bioengineered Protein Drugs Price by Type (2012-2017)
4.4 United States Bioengineered Protein Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES BIOENGINEERED PROTEIN DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Bioengineered Protein Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Bioengineered Protein Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES BIOENGINEERED PROTEIN DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Bioengineered Protein Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
  6.2.2 Bioengineered Protein Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Johnson & Johnson Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Bioengineered Protein Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Novartis
  6.4.2 Bioengineered Protein Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novartis Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.2 Bioengineered Protein Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Eli Lilly
  6.6.2 Bioengineered Protein Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Eli Lilly Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 F. Hoffmann-La Roche
  6.7.2 Bioengineered Protein Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 F. Hoffmann-La Roche Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Dr. Reddy's Laboratories
  6.8.2 Bioengineered Protein Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Dr. Reddy's Laboratories Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Abbott Laboratories
  6.9.2 Bioengineered Protein Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Abbott Laboratories Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Amgen
  6.10.2 Bioengineered Protein Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Amgen Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Bayer AG
6.12 Biocon
6.13 Fresenius kabi
6.14 Panacea Biotec
6.15 ProBioGen AG
6.16 Reliance Life Science

7 BIOENGINEERED PROTEIN DRUGS MANUFACTURING COST ANALYSIS

7.1 Bioengineered Protein Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Bioengineered Protein Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Bioengineered Protein Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES BIOENGINEERED PROTEIN DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Bioengineered Protein Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Bioengineered Protein Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Bioengineered Protein Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Bioengineered Protein Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Bioengineered Protein Drugs
Figure United States Bioengineered Protein Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Bioengineered Protein Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Monoclonal Antibodies Product Picture
Figure Therapeutic Proteins Product Picture
Figure Vaccines Product Picture
Figure United States Bioengineered Protein Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Bioengineered Protein Drugs by Application in 2016
Figure Pharma and Biotech Companies Examples
Table Key Downstream Customer in Pharma and Biotech Companies
Figure CROs Examples
Table Key Downstream Customer in CROs
Figure Academics Examples
Table Key Downstream Customer in Academics
Figure United States Bioengineered Protein Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Bioengineered Protein Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Bioengineered Protein Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Bioengineered Protein Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Bioengineered Protein Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Bioengineered Protein Drugs Sales Share by Players/Suppliers
Figure 2017 United States Bioengineered Protein Drugs Sales Share by Players/Suppliers
Figure United States Bioengineered Protein Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Bioengineered Protein Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Bioengineered Protein Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Bioengineered Protein Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Bioengineered Protein Drugs Revenue Share by Players/Suppliers
Table United States Market Bioengineered Protein Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Bioengineered Protein Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Bioengineered Protein Drugs Market Share of Top 3 Players/Suppliers
Figure United States Bioengineered Protein Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Bioengineered Protein Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Bioengineered Protein Drugs Product Category
Table United States Bioengineered Protein Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Bioengineered Protein Drugs Sales Share by Region (2012-2017)
Figure United States Bioengineered Protein Drugs Sales Share by Region (2012-2017)
Figure United States Bioengineered Protein Drugs Sales Market Share by Region in 2016
Table United States Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Bioengineered Protein Drugs Revenue Share by Region (2012-2017)
Figure United States Bioengineered Protein Drugs Revenue Market Share by Region (2012-2017)
Figure United States Bioengineered Protein Drugs Revenue Market Share by Region in 2016
Table United States Bioengineered Protein Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Bioengineered Protein Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Bioengineered Protein Drugs Sales Share by Type (2012-2017)
Figure United States Bioengineered Protein Drugs Sales Share by Type (2012-2017)
Figure United States Bioengineered Protein Drugs Sales Market Share by Type in 2016
Table United States Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Bioengineered Protein Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bioengineered Protein Drugs by Type (2012-2017)
Figure Revenue Market Share of Bioengineered Protein Drugs by Type in 2016
Table United States Bioengineered Protein Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Bioengineered Protein Drugs Sales Growth Rate by Type (2012-2017)
Table United States Bioengineered Protein Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Bioengineered Protein Drugs Sales Market Share by Application (2012-2017)
Figure United States Bioengineered Protein Drugs Sales Market Share by Application (2012-2017)
Figure United States Bioengineered Protein Drugs Sales Market Share by Application in 2016
Table United States Bioengineered Protein Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Bioengineered Protein Drugs Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Bioengineered Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Bioengineered Protein Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Bioengineered Protein Drugs Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Bioengineered Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Bioengineered Protein Drugs Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Bioengineered Protein Drugs Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Bioengineered Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Merck Bioengineered Protein Drugs Sales Market Share in United States (2012-2017)
Figure Merck Bioengineered Protein Drugs Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Bioengineered Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Novartis Bioengineered Protein Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Bioengineered Protein Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Bioengineered Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Bioengineered Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly Bioengineered Protein Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly Bioengineered Protein Drugs Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Bioengineered Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Bioengineered Protein Drugs Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche Bioengineered Protein Drugs Revenue Market Share in United States (2012-2017)
Table Dr. Reddy's Laboratories Basic Information List
Table Dr. Reddy's Laboratories Bioengineered Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dr. Reddy's Laboratories Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratories Bioengineered Protein Drugs Sales Market Share in United States (2012-2017)
Figure Dr. Reddy's Laboratories Bioengineered Protein Drugs Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Bioengineered Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Bioengineered Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Amgen Bioengineered Protein Drugs Sales Market Share in United States (2012-2017)
Figure Amgen Bioengineered Protein Drugs Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Biocon Basic Information List
Table Fresenius kabi Basic Information List
Table Panacea Biotec Basic Information List
Table ProBioGen AG Basic Information List
Table Reliance Life Science Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bioengineered Protein Drugs
Figure Manufacturing Process Analysis of Bioengineered Protein Drugs
Figure Bioengineered Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Bioengineered Protein Drugs Major Players/Suppliers in 2016
Table Major Buyers of Bioengineered Protein Drugs
Table Distributors/Traders List
Figure United States Bioengineered Protein Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Bioengineered Protein Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Bioengineered Protein Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Bioengineered Protein Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Bioengineered Protein Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Bioengineered Protein Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Bioengineered Protein Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Bioengineered Protein Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Bioengineered Protein Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Bioengineered Protein Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Bioengineered Protein Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Bioengineered Protein Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories